The landscape of molecular testing is shifting rapidly as healthcare providers prioritize speed and accuracy in detecting pulmonary pathogens. Central to this evolution is the PCR Respiratory Diagnostics Market Size, which is currently experiencing a period of significant capital investment and technological integration. By utilizing nucleic acid amplification, clinical laboratories can now...